Skip to main content

and
  1. Article

    Open Access

    Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

    Serum phosphorus control is critical for chronic kidney disease (CKD) 5D patients. Currently, clinical profile for an oral phosphorus binder in the mainland Chinese population is not available.

    **g Xu, Yi-**ang Zhang, Xue-Qing Yu, Zhi-Hong Liu, Li-Ning Wang in BMC Nephrology (2013)